PFC
PGNX
Phocas Financial Corp’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-1,022,708
| Closed | -$5.17M | – | 206 |
|
2019
Q3 | $5.17M | Sell |
1,022,708
-10,620
| -1% | -$53.7K | 0.55% | 77 |
|
2019
Q2 | $6.38M | Sell |
1,033,328
-112,964
| -10% | -$697K | 0.68% | 66 |
|
2019
Q1 | $5.32M | Sell |
1,146,292
-551,957
| -33% | -$2.56M | 0.53% | 84 |
|
2018
Q4 | $7.13M | Sell |
1,698,249
-38,137
| -2% | -$160K | 0.8% | 54 |
|
2018
Q3 | $10.9M | Sell |
1,736,386
-26,592
| -2% | -$167K | 0.95% | 38 |
|
2018
Q2 | $14.2M | Sell |
1,762,978
-16,546
| -0.9% | -$133K | 1.22% | 15 |
|
2018
Q1 | $13.3M | Buy |
1,779,524
+340,217
| +24% | +$2.54M | 1.2% | 20 |
|
2017
Q4 | $8.56M | Sell |
1,439,307
-60,978
| -4% | -$363K | 0.72% | 64 |
|
2017
Q3 | $11K | Buy |
1,500,285
+33,537
| +2% | +$246 | 0.92% | 47 |
|
2017
Q2 | $9.96M | Buy |
1,466,748
+65,491
| +5% | +$445K | 0.9% | 47 |
|
2017
Q1 | $13.2M | Sell |
1,401,257
-190,205
| -12% | -$1.8M | 1.23% | 16 |
|
2016
Q4 | $13.8M | Sell |
1,591,462
-1,626
| -0.1% | -$14K | 0.91% | 24 |
|
2016
Q3 | $10.1M | Buy |
1,593,088
+943,793
| +145% | +$5.97M | 0.7% | 45 |
|
2016
Q2 | $2.74M | Buy |
649,295
+39,332
| +6% | +$166K | 0.2% | 180 |
|
2016
Q1 | $2.66M | Sell |
609,963
-25,370
| -4% | -$111K | 0.2% | 179 |
|
2015
Q4 | $3.9M | Buy |
635,333
+45,414
| +8% | +$278K | 0.31% | 156 |
|
2015
Q3 | $3.37M | Buy |
589,919
+40,632
| +7% | +$232K | 0.29% | 161 |
|
2015
Q2 | $4.1M | Sell |
549,287
-706,358
| -56% | -$5.27M | 0.33% | 148 |
|
2015
Q1 | $7.51M | Buy |
1,255,645
+208,464
| +20% | +$1.25M | 0.6% | 70 |
|
2014
Q4 | $7.92M | Sell |
1,047,181
-42,564
| -4% | -$322K | 0.69% | 43 |
|
2014
Q3 | $5.66M | Buy |
1,089,745
+157,865
| +17% | +$819K | 0.51% | 90 |
|
2014
Q2 | $4.02M | Buy |
931,880
+126,285
| +16% | +$544K | 0.35% | 130 |
|
2014
Q1 | $3.3M | Buy |
805,595
+180,522
| +29% | +$738K | 0.32% | 134 |
|
2013
Q4 | $3.33M | Buy |
+625,073
| New | +$3.33M | 0.31% | 144 |
|